Chungcheongbuk-do, South Korea

Su-Min Park



Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Su-Min Park: Innovator in Aminopyrimidine Derivatives

Introduction

Su-Min Park is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminopyrimidine derivatives. With a total of 4 patents to his name, Park's work has garnered attention for its potential applications in treating various medical conditions.

Latest Patents

One of Su-Min Park's latest patents is a process for preparing aminopyrimidine derivatives. This invention provides an improved method for synthesizing aminopyrimidine derivatives or pharmaceutically acceptable salts that exhibit selective inhibitory activity against protein kinases. This is especially relevant for targeting mutant epidermal growth factor receptors. The patent also includes novel intermediates that are useful for this process and outlines methods for preparing these intermediates.

Career Highlights

Su-Min Park is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the company's portfolio of therapeutic solutions.

Collaborations

Throughout his career, Su-Min Park has collaborated with several talented individuals, including Sang-Ho Oh and Ja-Heouk Khoo. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

In summary, Su-Min Park is a distinguished inventor whose work in aminopyrimidine derivatives has the potential to impact the pharmaceutical industry significantly. His innovative approaches and collaborations continue to drive advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…